FDA Clears AdvanDx Test for Gram-negative Bloodstream Infection
January 17, 2011
FDA Clears AdvanDx Test for Gram-negative Bloodstream Infection
The test is the first capable of simultaneously identifying Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa directly from blood cultures containing Gram-negative rods in less than 90 minutes.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.